Menu
Recruiting NCT07254351

Analysis of the Biomechanical Impact of Lower Limb Length Inequality in PEDiatrics

Observational Lower Limb Length Discrepancy (LLD) in Children

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: EOS Imaging System, Force Platform (Bertec®, integrated into EOS cabin).
Who it may be relevant to
Registry conditions: Lower Limb Length Discrepancy (LLD) in Children. Basic parameters: 10 years — 15 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Biomechanical Analysis of the Impact of Lower Limb Length Discrepancy on Hip and Lumbar Spine Joints in Children

Overview

Lower limb length discrepancy (LLD) is a frequent condition in pediatric orthopedics. Even moderate discrepancies can induce pelvic obliquity and compensatory scoliosis, modifying the distribution of joint loads at the hips and lumbar spine. These biomechanical imbalances are suspected to contribute to early degenerative conditions such as osteoarthritis or chronic low back pain. The aim of this study is to quantify the biomechanical impact of LLD in children aged 10 to 15 years, using a combination of low dose biplanar EOS imaging (EOS Imaging System) and synchronized ground reaction force (GRF) measurements from integrated force platforms. These data will be used in musculoskeletal models developed in collaboration with the Biomechanics and Impact Mechanics Laboratory (LBMC, Laboratoire de Biomécanique et Mécanique des Chocs), enabling the estimation of hip joint and lumbar intervertebral disc loads. This is the first pediatric study integrating EOS imaging, force platforms, and personalized musculoskeletal modeling to explore the mechanical consequences of LLD. The findings are expected to improve clinical reasoning and guide early therapeutic strategies.

Detailed description

Lower limb length discrepancy (LLD) is a frequent condition in pediatric orthopedics. Even moderate discrepancies can induce pelvic obliquity and compensatory scoliosis, modifying the distribution of joint loads at the hips and lumbar spine. These biomechanical imbalances are suspected to contribute to early degenerative conditions such as osteoarthritis or chronic low back pain.

The aim of this study is to quantify the biomechanical impact of LLD in children aged 10 to 15 years, using a combination of low dose biplanar EOS imaging (EOS Imaging System) and synchronized ground reaction force (GRF) measurements from integrated force platforms. These data will be used in musculoskeletal models developed in collaboration with the Biomechanics and Impact Mechanics Laboratory (LBMC, Laboratoire de Biomécanique et Mécanique des Chocs), enabling the estimation of hip joint and lumbar intervertebral disc loads.

A temporary orthopedic compensation (shoe lift) will also be tested to assess its immediate biomechanical effect. Participants will be evaluated at baseline (two EOS acquisitions: with and without compensation) and at 2 years (without compensation).

This is the first pediatric study integrating EOS imaging, force platforms, and personalized musculoskeletal modeling to explore the mechanical consequences of LLD. The findings are expected to improve clinical reasoning and guide early therapeutic strategies.

Interventions

  • Radiation EOS Imaging System
    Low-dose biplanar radiographs of the whole body in standing position (EOS Imaging System). At baseline, two EOS acquisitions will be performed in static standing position : one without compensation (natural position) and one with temporary orthopedic compensation (shoe lift under the shorter limb). At 24 months, one EOS acquisition will be performed without compensation. Each acquisition lasts a few seconds, with radiation exposure 5 to 10 times lower than conventional radiographs.
  • Device Force Platform (Bertec®, integrated into EOS cabin)
    Ground reaction force (GRF) measurements obtained from a force platform integrated in the EOS cabin. The platform records weight distribution and center of pressure during static standing posture. Measurements are fully synchronized with EOS acquisitions, without additional time or discomfort for participants. At baseline, GRF measurements will be collected in two conditions (with and without orthopedic compensation). At 24 months, GRF measurements will be collected in the non-compensated condit

Primary outcome measures

  • Asymmetry of Hip Joint Contact Forces (%) in Static Standing [Time frame: At baseline (Day 0, without compensation)]

Eligibility criteria

Inclusion criteria

  • Children aged 10-15 years
  • Anatomical LLD > 5 mm, clinically measured
  • EOS imaging indicated by the pediatric orthopedic surgeon in routine care
  • Ability to stand still for 30 seconds without assistance
  • Covered by social security
  • Parental consent and non-opposition obtained

Exclusion criteria

  • \- Functional or postural LLD without true anatomical discrepancy
  • History of major pelvic or spinal surgery
  • Severe neurological or orthopedic condition preventing standing (e.g. cerebral palsy, progressive myopathy)
  • Fixed equinus deformity preventing plantar support
  • Major lower limb deformity (severe genu varum/valgum)
  • Contraindication or inability to undergo EOS imaging

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

France · 1 center
  • Hospices Civils de Lyon Service d'Orthopédie et de Traumatologie — Bron

Identifiers

NCT: NCT07254351 · 69HCL25_0746 · 2025-A01923-46

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗